1. Euroscreen S.a. (13 from 33 patents)

2. Novartis Ag (1 from 3,923 patents)

3. Odega S.a. (1 from 1 patent)

4. Epics Therapeutics (6 patents)

5. Ann Vandenbogaerde (0 patent)

6. Marc Parmentier (0 patent)

7. Valerie Wittamer (0 patent)

8. Michel Detheux (0 patent)

9. David Communi (0 patent)

10. Didier Communi (0 patent)

11. Jean-marie Boeynaems (0 patent)

12. Nathalie Suarez (0 patent)

13. Vincent Lannoy (0 patent)

14. Stephane Brezillon (0 patent)

1. 10203327 - Organic compounds

2. 8030453 - Methods of making an antibody that binds a chemerin polypeptide

3. 8003347 - Nucleic acids encoding ChemerinR ligands

4. 7858755 - Monoclonal antibodies that bind Chemerin polypeptide

5. 7842453 - Methods of identifying modulators of ChemerinR polypeptides

6. 7666401 - Compositions comprising a ligand of Chemerin R

7. 7582734 - Functional antibodies that specifically bind to the Chemerin receptor

8. 7470772 - Antibody that specifically binds to Chemerin receptor ligand precursor

9. 7422846 - Natural ligand for orphan G protein coupled receptor GPR86 and methods of use

10. 7419658 - Isolated ligand of ChemerinR

11. 7332291 - Methods of identifying modulators of ligand binding to ChemerinR polypeptides

12. 7303889 - Ligand for G-protein coupled receptor GPR43 and uses thereof

13. 6946244 - Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)

14. 6872538 - High-throughput screening diagnostic and/or dosage method of an agonist and/or an antagonist for a calcium-coupled receptor